Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation
El-Nahas, Tamer, Kader, Yasser, Le Chevalier,, Sakr, AmrLanguage:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S45906
Date:
July, 2013
File:
PDF, 454 KB
english, 2013